Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma

Drug resistance limits the therapeutic efficacy in cancers and leads to tumor recurrence through ill-defined mechanisms. Glioblastoma (GBM) are the deadliest brain tumors in adults. GBM, at diagnosis or after treatment, are resistant to temozolomide (TMZ), the standard chemotherapy. To better unders...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabé, Marion, Dumont, Solenne, Álvarez-Arenas, Arturo, Janati, Hicham, Belmonte-Beitia, Juan, Calvo, Gabriel F., Thibault-Carpentier, Christelle, Séry, Quentin, Chauvin, Cynthia, Joalland, Noémie, Briand, Floriane, Blandin, Stéphanie, Scotet, Emmanuel, Pecqueur, Claire, Clairambault, Jean, Oliver, Lisa, Perez-Garcia, Victor, Nadaradjane, Arulraj, Cartron, Pierre-François, Gratas, Catherine, Vallette, François M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944699/
https://www.ncbi.nlm.nih.gov/pubmed/31907355
http://dx.doi.org/10.1038/s41419-019-2200-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944699/
https://www.ncbi.nlm.nih.gov/pubmed/31907355
http://dx.doi.org/10.1038/s41419-019-2200-2

Ejemplares similares